RecruitingNCT06349681
Describe Relations Between qCON and qNOX Indicies During Propofol-Remifentanil General Anesthesia
Describe Relationship Between qCON and qNOX of the CONOX Monitor During General Anesthesia Perfromed With Propofol and Remifentanil Target Controlled Infusion (TCI)
Sponsor
University of Padova
Enrollment
14 participants
Start Date
Apr 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years
Inclusion Criteria1
- Undergo general anaesthesia with Targeted Controlled Infusion of Propofol (Eleveld or Schnider model) and Remifentanil (Minto model) and CONOX monitoring
Exclusion Criteria4
- Neurological disease
- Psychiatric disease
- Obesity
- Locoregional anesthesia
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06349681